ContextVision

Less than 1K followers

CONTX

Oslo Børs

Medical Equipment & Services

Health Care

Overview

Investor consensus

ContextVision is a medical technology company. The company specializes in image analysis and artificial intelligence. The company's products include advanced image enhancement software for ultrasound, MRI, X-ray and mammography. The software is used by hospitals and research institutes worldwide. The company was founded in 1983 and is headquartered in Stockholm.

Market cap

-

Turnover

-

Revenue

120.53M

EBIT %

0.38 %

P/E

-

Dividend yield-%

-

Financial calendar

8/5

2026

Interim report Q1'26

12/5

2026

General meeting '26

27/8

2026

Interim report Q2'26

All

Press releases

ShowingAll content types

Press releaseyesterday

ContextVision announces changes to its management team and strengthens its technology leadership with appointment of new CTO

Regulatory press release2/25/2026, 4:04 PM

ContextVision AB: Transactions made under the buy-back programme

Regulatory press release2/19/2026, 9:02 AM

CONTX: Financial calendar

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Regulatory press release2/19/2026, 7:00 AM

ContextVision AB: Year-end report 2025 – Substantial progress in transformation amid early signs of stabilization

Regulatory press release2/18/2026, 3:50 PM

ContextVision announces extended share buy-back programme

Regulatory press release2/16/2026, 4:16 PM

ContextVision AB: Transactions made under the buy-back programme

Regulatory press release2/5/2026, 4:00 PM

ContextVision AB: Transactions made under the buy-back programme

Regulatory press release1/27/2026, 4:17 PM

ContextVision AB: Transactions made under the buy-back programme

Regulatory press release1/16/2026, 4:26 PM

ContextVision AB: Transactions made under the buy-back programme

Regulatory press release1/7/2026, 5:36 PM

ContextVision AB: Transactions made under the buy-back programme

Regulatory press release12/22/2025, 4:25 PM

ContextVision AB: Transactions made under the buy-back programme

Regulatory press release12/11/2025, 4:08 PM

ContextVision AB: Transactions made under the buy-back programme

Press release12/10/2025, 12:08 PM

ContextVision initiates the clinical phase of its point-of-care ultrasound innovation venture to advance liver disease diagnostics

Regulatory press release12/2/2025, 5:45 PM

ContextVision AB: Transactions made under the buy-back programme

Regulatory press release12/1/2025, 10:25 AM

CONTX: Financial calendar

Regulatory press release11/21/2025, 4:10 PM

ContextVision AB: Transactions made under the buy-back programme

Regulatory press release11/12/2025, 4:11 PM

ContextVision AB: Transactions made under the buy-back programme

Regulatory press release11/6/2025, 7:00 AM

ContextVision AB: Q3 interim report 2025 – Navigating market uncertainty while making solid progress with our Data Quality initiative

Regulatory press release11/3/2025, 3:50 PM

ContextVision AB: Transactions made under the buy-back programme

Regulatory press release10/23/2025, 3:08 PM

ContextVision AB: Transactions made under the buy-back programme

Forum discussions

Yleistä ContextVision AB (CONTX) on lääketieteellisiin kuva-analyysiratkaisuihin (algoritmeihin) erikoistunut yritys, ja sen liiketoiminnan ydintä ovat kuvankäsittely, tekoäly ja lääketieteellinen diagnostiikka sekä erityisesti näihin liittyvät ohjelmistoratkaisut. Yritys on sanojensa...

11/27/2023, 1:16 PM

by timontti

71

I also asked AI about the competitive landscape. There are plenty of them

11/27/2023, 5:33 PM

by timontti

6

Annual report published https://www.contextvision.com/contextvision-publishes-annual-report-for-the-fiscal-year-2023/ P.S. You can also add Norwegian companies to your watchlist through the Inderes service, even if they don’t have analyst coverage. At least you’ll get notifications...

4/12/2024, 9:07 AM

by timontti

3

Read more on our forum

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.